IN THE NEWS
NEWS
NATIONAL CANCER CAMPAIGN LAUNCH 30 OCTOBER 2018
PRESS RELEASE: NATIONAL CANCER CAMPAIGN For immediate release. Kindly redistribute as widely as possible! 30th October 2018: The National Cancer Campaign (NCC), announced by President Cyril Ramaphosa on 16 February, 2018 will be launched today in...
CANCER ALLIANCE PUBLISHES SECTION 4 OF THE ADVOCACY TOOLKIT ON THE NEW PALLIATIVE CARE POLICY: STORIES OF HOPE, CARE AND SURVIVAL
National Policy Framework and Strategy for Palliative Care 2017-2022 The Cancer Alliance today releases the fourth and last in its series on the new National Policy Framework and Strategy for Palliative Care 2017-2022 - Section 4: Stories of Hope, Care and Survival...
CANCER ALLIANCE PUBLISHES IMPORTANT NEW STUDY ON BREAST CANCER AND TRASTUZUMAB ACCESS IN SOUTH AFRICA
The Cancer Alliance today publishes an important new study BREAST CANCER and HER2+ BREAST CANCER WITH A LOOK AT TRASTUZUMAB ACCESS IN SOUTH AFRICA. Breast cancer is the most common cancer in South Africa. It is also the second highest cancer killer of our women. At...
FIRST BIOSIMILAR DRUG APPROVED IN SOUTH AFRICA BUT PRICE IS STILL HIGH
Teva Pharmaceutical Industries has obtained approval to sell the first biosimilar drug Filgrastim Teva in South Africa Business Day today reports that Teva Pharmaceutical Industries has become the first company to have a biosimilar drug approved for sale in SA....
CANCER ALLIANCE PUBLISHES SECTION 3 OF THE ADVOCACY TOOLKIT ON THE NEW PALLIATIVE CARE POLICY: CANCER AND CHILDREN
National Policy Framework and Strategy for Palliative Care 2017-2022 The Cancer Alliance today releases the third in its series on the new National Policy Framework and Strategy for Palliative Care 2017-2022 - Section 3: Cancer and Children. Today's release covers the...
VISION CANCER NEWSLETTER – JUNE 2018
[icon name="eye" class="" unprefixed_class=""] VISION Newsletter for June 2018 In this month's issue: New SA Intellectual Property Policy approved - Support for prostate cancer patients on the East Rand - Fighting fake medicines around the world - Coping with a...
CANCER ALLIANCE PUBLISHES SECTION 2 OF THE ADVOCACY TOOLKIT ON THE NEW PALLIATIVE CARE POLICY: ADULTS WITH CANCER
National Policy Framework and Strategy for Palliative Care 2017-2022 The Cancer Alliance today releases the second in its series on the new National Policy Framework and Strategy for Palliative Care 2017-2022 - Section 2: Adults with Cancer. Today's release covers the...
VISION CANCER NEWSLETTER – MAY 2018
[icon name="eye" class="" unprefixed_class=""] VISION Newsletter for May 2018 In this month's issue: Have your say on the new draft tobacco legislation - Phoenix North Coast Cancer Support Group partnership to provide free cancer screening - Price competition...
Cancer Care Crisis
South Africa is facing a #CancerCareCrisis. Cancer care is a basic human right, but Tina passed away in December because Baragwanath Hospital did not have the drip medicine that was making her better. Read Tina’s story. As Ziphora experienced, machines aren’t working and she is not getting the #palliative care…
TIMELINE OF ACCESS TO TRASTUZUMAB IN SOUTH AFRICA
People are dying because big pharmaceutical companies like Roche are doing everything possible to exploit any loopholes which enable the sale of life-saving medicine for obscene profits. This timeline of Trastuzumab—a breast cancer medicine developed through public and private funding many decades ago—tells the story of the long and ongoing…
WHY INTELLECTUAL PROPERTY REFORM IN SOUTH AFRICA WILL HELP NOT HURT ECONOMIC DEVELOPMENT AND INNOVATION IN THE COUNTRY
Sensible reforms to South Africa’s patent laws will not harm the economy or inhibit domestic innovation. To the contrary, in this paper we provide evidence that sensible reforms can both stimulate the economy and bolster innovation – all while improving the access that people living in South Africa have to…
MAVERICK CITIZEN: HEALTH Dying for Treatment: The struggle for affordable breast cancer medicines in South Africa
Across the world, October is marked as breast cancer month. It is an opportunity to create awareness, educate people and provide support for breast cancer survivors and those close to them. In South Africa, more than 10 dedicated breast cancer organisations do their bit. No other single cancer in South…
Cancer Alliance publishes the first
fact sheet on biosimilars in South Africa
Biosimilars are pharmaceutical products that are almost identical copies of existing medicines. Cancer Alliance publishes the first fact sheet on biosimilars in South Africa. The approval and availability of biosimilars will influence access and affordability of lifesaving medicines. Patients, clinicians and funders need to informed about these new opportunities to ensure that patients always have…
SANCDA LETTER AND REPORT TO MINISTER OF HEALTH
Letter and Report to the Minister of Health, Dr Zweli Mkhize, from the South African Non-Communicable Diseases Alliance Please download and read the following two important documents: Letter to the new Minister of Health requesting urgent consultation and proposing important interventions in support of transition consistent with the SDGs and…
BREAST CANCER FACT SHEETS
Download the following Fact Sheets: https://old.canceralliance.org.za/wp-content/uploads/2019/09/Breast-Cancer-Symptoms-Fact-Sheet-V0.pdf https://old.canceralliance.org.za/wp-content/uploads/2019/09/Breast-Cancer-Risk-Factors-Fact-Sheet-V0.pdf
PATIENT STORY: RETHA WESSELS
RETHA WESSELS, 57DIAGNOSED WITH MULTIPLE MYELOMA “I was diagnosed with multiple myeloma in April 2012, and in November applied to my medical scheme for a stem cell transplant. They indicated that I first required chemotherapy treatment with a co-payment of about R40,000. After complying, stem cell treatment coverage was approved…
SUE JOHNSON SPEAKS ABOUT MULTIPLE MYELOMA AND LENALIDOMIDE
Sue Johnson and Lenalidomide Sue Johnson was diagnosed with breast cancer in 2008 and with Multiple Myeloma in 2014. While she was initially able to access a generic lenalidomide treatment from India on a Section 21 authorisation from the Medicines Control Council at a price of about R5000 per month,…
PATIENT STORY: JAYNE HEWISON
Jayne Hewison, diagnosed with multiple myeloma I am an 8 year survivor of Multiple Myeloma, an as-yet incurable cancer of the blood. I’ve had 2 stem cell transplants and don’t have much alternative to treatment with lenalidomide. Towards the end of 2016, while being treated in Kwazulu Natal by a…
PATIENT STORY: GRANT DAVIES
Grant Davies, diagnosed with multiple myeloma In April 2014, I was diagnosed with a rare blood cancer called Multiple Myeloma. I was 43 at the time, a husband, and father to a 5 year old. My treatment included radiation, chemotherapy, and two stem cell transplants. I had a good response,…
PATIENT STORY: VENO GOVENDER
Veno Govender, diagnosed with multiple myeloma My name is Veno Govender. I’m from South Africa in the city of Cape Town. A plasmacytoma was found in my right humerus in December 2016. Since then I have had a humerus replacement, Chemo and a SCT Further to that upon all the…
PATIENT STORY: TEBOHO SHAI
Teboho Shai, diagnosed with multiple myeloma I was diagnosed with stage 3 B Multiple Myeloma at age 57 in April 2016 and consequently became paralysed. At the time I was living in Pretoria self employed as a consultant. I am married to Veliswa and I’m a proud father of 6…
MOTIVATION FOR: PROMPT APPROVAL OF TRASTUZUMAB BIOSIMILARS TO PROMOTE COMPETITION IN THE MARKET
17 July 2019: Cancer Alliance submits a motivation to SAHPRA for the prompt approval of trastuzumab biosimilars to promote competition in the market. The Cancer Alliance of South Africa submits this memorandum in support of its request that SAHPRA promptly register biosimilars of the breast cancer medicine trastuzumab for which…
LAUNCHING THE CAMPAIGN FOR ACCESS TO AFFORDABLE LENALIDOMIDE
Minister Mkhize must ensure access to cancer medicine that WHO now considers “essential” Johannesburg (9 July 2019) — It was announced today that lenalidomide, a lifesaving medicine to treat multiple myeloma, has been included on the latest edition of the World Health Organisation’s (WHO) Essential Medicines List (EML). Welcoming the…
SANCDA LETTER AND REPORT TO MINISTER OF HEALTH – JUNE 2019
Letter and Report to the Minister of Health, Dr Zweli Mkhize, from the South African Non-Communicable Diseases Alliance Please download and read the following two important documents: Letter to the new Minister of Health requesting urgent consultation and proposing important interventions in support of transition consistent with the SDGs and…
CANCER ALLIANCE PUBLISHES SECTION 4 OF THE ADVOCACY TOOLKIT ON THE NEW BREAST CANCER POLICY: TREATMENT & PALLIATIVE CARE
Breast Cancer Control Policy 2017 25th February 2019 The Cancer Alliance today publishes the fourth and final part of its series on the Breast Cancer Control Policy with Section 4: Treatment & Palliative Care South Africa’s new Breast Cancer Control Policy is a vital document aimed at prioritising breast cancer…
CANCER ALLIANCE CALLS FOR AFFORDABLE LENALIDOMIDE
Cancer Alliance calls for access to affordable lenalidomide for public and private sector patients in South Africa EMBARGOED UNTIL FRIDAY FEBRUARY 15 Many cancer patients in South Africa do not have access to affordable cancer medicines – many of which are available in other countries at a fraction of the…
CANCER ALLIANCE PUBLISHES SECTION 3 OF THE ADVOCACY TOOLKIT ON THE NEW BREAST CANCER POLICY: ACCESS TO CARE
Breast Cancer Control Policy 2017 14th December 2018 The Cancer Alliance today publishes the third part of its series on the Breast Cancer Control Policy with Section 3: Access to Care. South Africa’s new Breast Cancer Control Policy is a vital document aimed at prioritising breast cancer awareness, prevention, treatment…
Use mouse wheel to scroll though stories